Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.0K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.0K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.4K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.4K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

956
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
956
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

546
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
546

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Orthostatic Myoclonus-Clinical and Electrophysiological Features in a Large Retrospective Cohort.

Movement disorders clinical practice·2026
Same author

Optimising DBS in essential tremor: clinical and neurophysiological considerations for targeting and programming.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Predictive accuracy of gait speed for falls: An individual participant data meta-analysis.

Ageing research reviews·2026
Same author

Data-Driven Insights into Hyperkinetic Disorders in Neurodevelopmental Syndromes and Epileptic Encephalopathies.

Movement disorders clinical practice·2026
Same author

Foslevodopa/Foscarbidopa Subcutaneous Infusion Safety and Efficacy in Patients with and Without Prior Deep Brain Stimulation.

Advances in therapy·2026
Same author

MITO-VATION: Feasibility of a technology-supported structured home exercise program in Mitochondrial Disease.

PLOS digital health·2026

Related Experiment Video

Updated: Feb 2, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.3K

Parkinson disease.

Samuel D Kim1, Natalie E Allen2, Colleen G Canning2

  • 1Movement Disorders Unit, Department of Neurology, Westmead Hospital and Sydney Medical School, University of Sydney, Sydney, NSW, Australia.

Handbook of Clinical Neurology
|November 29, 2018
PubMed
Summary
This summary is machine-generated.

Parkinson disease (PD) causes gait and balance issues, leading to frequent falls. Early identification of risk factors and interventions like exercise can improve mobility and reduce fall frequency in PD patients.

Keywords:
Parkinson diseaseaccidental fallsbalanceexercisegaitmedical and nonmedical interventions

More Related Videos

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
03:20

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

2.4K
Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.4K

Related Experiment Videos

Last Updated: Feb 2, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.3K
Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
03:20

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

2.4K
Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.4K

Area of Science:

  • Neurology
  • Movement Disorders
  • Geriatrics

Background:

  • Parkinson disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms.
  • Gait disturbance, balance problems, and falls are prevalent and progressive issues in PD patients.
  • Freezing of gait (FOG) is a particularly disabling feature, increasing with disease duration.

Purpose of the Study:

  • To review the clinical, pathologic, and physiologic aspects of gait disturbance and falls in PD.
  • To examine the evidence supporting various medical and non-medical interventions for improving gait and reducing falls in PD.

Main Methods:

  • Literature review of clinical, pathologic, and physiologic correlates of gait and falls in PD.
  • Analysis of evidence for therapeutic interventions, including pharmacologic and non-pharmacologic approaches.

Main Results:

  • Falls are common in PD, with a high rate of recurrence.
  • Identified risk factors for falls include history of falls, FOG, impaired balance, reduced leg strength, mobility deficits, cognitive impairment, and fear of falling.
  • Interventions such as levodopa, deep-brain stimulation, cuing strategies, and exercise show potential for improving physical function and mobility.

Conclusions:

  • Gait disturbance and falls are significant challenges in Parkinson disease management.
  • A multifactorial approach addressing identified risk factors and utilizing available therapies is crucial for enhancing patient mobility and safety.